Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer

72Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We previously observed that the HERV type K (HERV-K) envelope (env) protein was expressed in the majority of human breast tumors from a U.S. cohort of women from Texas. We also made the preliminary observation that the expression of HERV-K env transcripts was associated with markers of disease progression. In this follow-up study, env protein expression was evaluated immunohistochemically in an additional 195 paraffin-embedded breast tumors from a second U.S. patient cohort (Baltimore, Maryland) and in 110 tumors from Chinese patients. Moreover, we compared env transcript expression between fresh-frozen normal and cancerous breast tissues. We observed that while env mRNA and protein expression was undetectable in normal breast tissue and in a subset of uninvolved normal-appearing tissue adjacent to the tumor epithelium, it was overexpressed in most tumors. Furthermore, env expression was associated with breast cancer progression. In Baltimore cohort women, HERV-K tumor positivity was significantly associated with disease stage and lymph node metastasis. In Chinese women, HERV-K env positivity was significantly associated with tumor size, TNM stage, and lymph node metastases, which is consistent with the observations in the U.S. cohort. We also found that Chinese breast cancer patients with a high expression of HERV-K had a decreased overall survival compared with patients who had either a moderate or low HERV-K expression in their tumors (P = 0.049, χ2 log rank test). In conclusion, the HERV-K env gene is expressed in the majority of breast cancers from U.S. or Chinese women but not in normal breast tissue. High expression of HERV-K env protein in breast cancer patients is associated with markers of disease progression and poor disease outcome, indicating that HERV-K env protein is a novel candidate prognostic marker for breast cancer. © The Author(s) 2011.

References Powered by Scopus

Global cancer statistics

31591Citations
N/AReaders
Get full text

"Westernizing" women's risks? Breast cancer in lower-income countries

444Citations
N/AReaders
Get full text

Some possible effects of nursing on the mammary gland tumor incidence in mice

389Citations
N/AReaders
Get full text

Cited by Powered by Scopus

HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity

159Citations
N/AReaders
Get full text

Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells

98Citations
N/AReaders
Get full text

Downregulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth

94Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhao, J., Rycaj, K., Geng, S., Li, M., Plummer, J. B., Yin, B., … Wang-Johanning, F. (2011). Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer. Genes and Cancer, 2(9), 914–922. https://doi.org/10.1177/1947601911431841

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 34

72%

Researcher 11

23%

Professor / Associate Prof. 2

4%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 18

37%

Biochemistry, Genetics and Molecular Bi... 12

24%

Immunology and Microbiology 11

22%

Medicine and Dentistry 8

16%

Save time finding and organizing research with Mendeley

Sign up for free